Sustained response rates were also significantly ( p < 0.05 ) higher among LDX-treated patients ( ADHD-RS-IV 25 , 66.1 % ; ADHD-RS-IV 30 , 61.4 % ; ADHD-RS-IV 50 , 41.7 % ; CGI-I , 52.0 % ) than among ATX-treated individuals ( ADHD-RS-IV 25 , 51.1 % ; ADHD-RS-IV 30 , 47.4 % ; ADHD-RS-IV 50 , 23.7 % ; CGI-I , 39.3 % ) .